Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EPR NYSE:EQC NYSE:NHI NASDAQ:PCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEPREPR Properties$59.25+2.1%$57.44$48.10▼$62.08$4.44B1.03635,646 shs472,113 shsEQCEquity Commonwealth$1.58$1.58$1.40▼$20.60$169.73M0.571.89 million shsN/ANHINational Health Investors$73.08+3.0%$75.42$67.94▼$91.38$3.44B0.52420,670 shs384,929 shsPCHPotlatch$41.73+0.0%$42.02$37.05▼$45.61$3.23B1.09663,908 shs13.28 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEPREPR Properties+0.78%-0.58%-1.11%+15.07%-0.52%EQCEquity Commonwealth0.00%0.00%0.00%0.00%0.00%NHINational Health Investors+0.30%+0.27%-7.35%-14.22%+0.14%PCHPotlatch0.00%0.00%0.00%0.00%+8.62%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEPREPR Properties$59.25+2.1%$57.44$48.10▼$62.08$4.44B1.03635,646 shs472,113 shsEQCEquity Commonwealth$1.58$1.58$1.40▼$20.60$169.73M0.571.89 million shsN/ANHINational Health Investors$73.08+3.0%$75.42$67.94▼$91.38$3.44B0.52420,670 shs384,929 shsPCHPotlatch$41.73+0.0%$42.02$37.05▼$45.61$3.23B1.09663,908 shs13.28 million shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEPREPR Properties+0.78%-0.58%-1.11%+15.07%-0.52%EQCEquity Commonwealth0.00%0.00%0.00%0.00%0.00%NHINational Health Investors+0.30%+0.27%-7.35%-14.22%+0.14%PCHPotlatch0.00%0.00%0.00%0.00%+8.62%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEPREPR Properties 2.58Moderate Buy$61.694.11% UpsideEQCEquity Commonwealth 0.00N/AN/AN/ANHINational Health Investors 2.88Moderate Buy$84.5715.72% UpsidePCHPotlatch 2.00Hold$45.839.83% UpsideCurrent Analyst Ratings BreakdownLatest EPR, PCH, EQC, and NHI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/15/2026NHINational Health Investors BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$90.00 ➝ $80.006/12/2026NHINational Health Investors Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)6/12/2026EPREPR Properties Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight6/12/2026EPREPR Properties CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Outperform6/12/2026EPREPR Properties Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$70.006/12/2026NHINational Health Investors Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$89.00 ➝ $81.006/9/2026EPREPR Properties Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$62.00 ➝ $61.006/1/2026EPREPR Properties Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$54.00 ➝ $60.006/1/2026NHINational Health Investors Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$84.00 ➝ $79.005/26/2026EPREPR Properties Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$59.00 ➝ $61.005/22/2026EPREPR Properties Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)(Data available from 6/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEPREPR Properties$718.36M6.31$6.07 per share9.76$30.59 per share1.94EQCEquity Commonwealth$58.43M2.90$0.93 per share1.69$21.28 per share0.07NHINational Health Investors$375.63M9.43$4.93 per share14.81$32.11 per share2.28PCHPotlatch$1.12B2.89$1.85 per share22.55$25.87 per share1.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEPREPR Properties$274.94M$3.2318.3410.772.3437.50%11.68%4.83%7/29/2026 (Estimated)EQCEquity Commonwealth$91.16M$0.394.05N/AN/A82.00%2.09%1.96%N/ANHINational Health Investors$142.18M$3.1023.5714.053.8136.86%9.82%5.35%8/5/2026 (Estimated)PCHPotlatch$21.88M$0.8250.8934.78N/A5.76%3.38%2.06%N/ALatest EPR, PCH, EQC, and NHI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026EPREPR Properties$0.76$0.74-$0.02$0.74$150.02 million$181.25 million5/4/2026Q1 2026NHINational Health Investors$1.21$0.82-$0.39$0.82$70.22 million$115.13 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEPREPR Properties$3.726.28%+18.29%115.17%1 YearsEQCEquity CommonwealthN/AN/A-100.00%N/AN/ANHINational Health Investors$3.685.04%-3.77%118.71%N/APCHPotlatch$1.804.31%+2.38%219.51%N/ALatest EPR, PCH, EQC, and NHI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/4/2026NHINational Health Investorsquarterly$0.924.86%6/30/20266/30/20268/7/20266/15/2026EPREPR Propertiesmonthly$0.316.38%6/30/20266/30/20267/15/20265/14/2026EPREPR Propertiesmonthly$0.316.52%5/29/20265/29/20266/15/20264/15/2026EPREPR Propertiesmonthly$0.316.66%4/30/20264/30/20265/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEPREPR Properties1.277.857.85EQCEquity CommonwealthN/A126.74126.73NHINational Health Investors0.838.208.20PCHPotlatch0.531.961.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEPREPR Properties74.66%EQCEquity Commonwealth96.00%NHINational Health Investors62.51%PCHPotlatch86.06%Insider OwnershipCompanyInsider OwnershipEPREPR Properties0.03%EQCEquity Commonwealth2.10%NHINational Health Investors2.70%PCHPotlatch1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEPREPR Properties6076.51 million76.49 millionOptionableEQCEquity Commonwealth20107.42 million105.08 millionNo DataNHINational Health Investors2048.47 million47.16 millionOptionablePCHPotlatch1,38377.29 million76.52 millionOptionableEPR, PCH, EQC, and NHI HeadlinesRecent News About These CompaniesHow Is Rayonier Inc (RYN)’s Newly Formed Wood Products Segment Doing?June 6, 2026 | insidermonkey.comRayonier Highlights Strategy and PotlatchDeltic Merger SynergiesMarch 2, 2026 | tipranks.comRayonier Faces Pension Funding Risks and Potential Cash Strain After PotlatchDeltic MergerFebruary 25, 2026 | tipranks.comA Look At PotlatchDeltic (PCH) Valuation After NASDAQ Composite Index RemovalFebruary 15, 2026 | finance.yahoo.comReal Estate Stocks To Keep An Eye On – February 9thFebruary 11, 2026 | defenseworld.netDConstruction Stocks To Keep An Eye On – February 9thFebruary 11, 2026 | defenseworld.netDTop Construction Stocks To Consider – February 6thFebruary 8, 2026 | defenseworld.netDReal Estate Stocks Worth Watching – February 6thFebruary 8, 2026 | defenseworld.netDRayonier Restructures Credit Facilities After PotlatchDeltic MergerFebruary 3, 2026 | tipranks.comRayonier, PotlatchDeltic shareholders approve mergerJanuary 27, 2026 | msn.comPotlatchDeltic Shareholders Approve Merger With RayonierJanuary 27, 2026 | tipranks.comRayonier Shareholders Approve PotlatchDeltic Merger Share IssuanceJanuary 27, 2026 | tipranks.comRayonier and PotlatchDeltic Announce Stockholder Approvals for MergerJanuary 27, 2026 | businesswire.comPotlatchDeltic (PCH) Q3 2025 Earnings TranscriptJanuary 26, 2026 | finance.yahoo.comAssessing PotlatchDeltic (PCH) Valuation After Recent Share Price MomentumJanuary 19, 2026 | finance.yahoo.comPotlatchDeltic issues supplemental disclosures amid merger lawsuitsJanuary 17, 2026 | theglobeandmail.comPotlatchDeltic Announces Tax Treatment for 2025 Dividend DistributionsJanuary 16, 2026 | businesswire.comPotlatch (NASDAQ:PCH) CAO Sells $30,848.40 in StockJanuary 13, 2026 | insidertrades.comAssessing PotlatchDeltic: Insights From 7 Financial AnalystsJanuary 9, 2026 | benzinga.comBMO Capital downgrades PotlatchDeltic (PCH)January 9, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20265 Under-the-Radar AI Stocks to Watch in JuneBy Thomas Hughes | May 31, 2026Will the SpaceX IPO Put These 5 Public Space Stocks Into a Higher Orbit?By Ryan Hasson | June 2, 2026SpaceX Valuation Loses Altitude as AI Risks MountBy Jeffrey Neal Johnson | June 23, 2026EPR, PCH, EQC, and NHI Company DescriptionsEPR Properties NYSE:EPR$59.25 +1.21 (+2.08%) Closing price 03:58 PM EasternExtended Trading$59.34 +0.09 (+0.16%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.EPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues that create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their discretionary time and money. We have total assets of approximately $5.7 billion (after accumulated depreciation of approximately $1.4 billion) across 44 states. We adhere to rigorous underwriting and investing criteria centered on key industry, property and tenant level cash flow standards. We believe our focused approach provides a competitive advantage and the potential for stable and attractive returns.Equity Commonwealth NYSE:EQC$1.58 0.00 (0.00%) As of 06/22/2026Equity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC's portfolio is comprised of four properties totaling 1.5 million square feet.National Health Investors NYSE:NHI$73.08 +2.12 (+2.99%) Closing price 03:58 PM EasternExtended Trading$75.34 +2.27 (+3.10%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.Potlatch NASDAQ:PCHPotlatchDeltic Corporation (Nasdaq: PCH) is a leading Real Estate Investment Trust (REIT) that owns nearly 2.2 million acres of timberlands in Alabama, Arkansas, Georgia, Idaho, Louisiana, Mississippi and South Carolina. Through its taxable REIT subsidiary, the company also operates six sawmills, an industrial-grade plywood mill, a residential and commercial real estate development business and a rural timberland sales program. PotlatchDeltic, a leader in sustainable forest management, is committed to environmental and social responsibility and to responsible governance. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
